Liu, Juan
Li, Meiqin
Fu, Jinhua
Yuan, Guiling
Li, Ning
Fu, Yinghui
Zhao, Long
Funding for this research was provided by:
China Health Promotion Foundation (XM_2020_011_0245_09)
National Natural Science Foundation of China (81800601)
China Postdoctoral Science Foundation (2019M652333)
Natural Science Foundation of Shandong Province (ZR2020QH060)
Qingdao Key Health Discipline Development Fund
Article History
Received: 22 January 2023
Accepted: 7 March 2023
First Online: 13 March 2023
Declarations
:
: This randomized controlled trial (RCT) was evaluated and approved by the medical ethical committee of our hospital. This study complied with Chinese laws and with the Good Clinical Practice (GCP) standards formulated by the National Drug Regulatory Department.
: The authors declare that they have no competing interests.